(Q43169783)

15 November 2017

title

MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings (English)

1 reference

15 November 2017

1 reference

J L Piñana

1

1 reference

15 November 2017

D Valcárcel

2

1 reference

15 November 2017

F Fernández-Avilés

3

1 reference

15 November 2017

R Martino

4

1 reference

15 November 2017

M Rovira

5

1 reference

15 November 2017

P Barba

6

1 reference

15 November 2017

C Martínez

7

1 reference

15 November 2017

S Brunet

8

1 reference

15 November 2017

A Sureda

9

1 reference

15 November 2017

E Carreras

10

1 reference

15 November 2017

J Sierra

11

1 reference

15 November 2017

language of work or name

English

0 references

publication date

8 February 2010

1 reference

Bone Marrow Transplantation

15 November 2017

published in

1 reference

15 November 2017

volume

45

1 reference

15 November 2017

issue

9

1 reference

15 November 2017

page(s)

1449-1456

1 reference

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Pharmacokinetics of oral mycophenolate mofetil in combination with CsA in dogs after nonmyeloablative allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

7 January 2021

Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

7 January 2021

Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

7 January 2021

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

7 January 2021

Administration of mycophenolate mofetil in a murine model of acute graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

7 January 2021

Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.362

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.362

1 reference

Dimensions Publication ID

15 November 2017

1025829761

0 references

1 reference